Cytodyn Inc (CYDY)

[dadbrotheroftwins]

My question to you and to misiu143 as doctors, is that the FDA has seemingly given other therapeutics preferred treatment, in that EUA's have been given with less efficacy shown, as well as having more side effects. As much as I have invested in CYDY, I would hate to have this continue with regards to the CD12 results. In your learned opinion or other doctors on this board, if the CD12 results are "stat sig" is there any way that the FDA could not give a EUA for leronlimab. Not trying to be a downer, just nervous due to the apparent preferential treatment we've seen, and what could be possibly a major pain for BP leronlimab could be if approved. I'm not having a problem with the length of time for release of results, just wondering if the FDA has said, this or that wasn't done right, and causing a delay, or a limited use EUA.